{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T03:08:31Z","timestamp":1791860911291,"version":"4.3.4"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1007\/s00467-007-0537-8","type":"journal-article","created":{"date-parts":[[2007,7,23]],"date-time":"2007-07-23T13:24:42Z","timestamp":1185197082000},"page":"1929-1937","source":"Crossref","is-referenced-by-count":86,"title":["Heritable forms of hypertension"],"prefix":"10.1007","volume":"24","author":[{"given":"V. Matti","family":"Vehaskari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,10,1]]},"reference":[{"key":"537_CR1","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/0002-9343(72)90050-2","volume":"52","author":"AC Guyton","year":"1972","unstructured":"Guyton AC, Coleman RG, Cowley AW Jr, Scheel KW, Manning RD Jr, Norman RA Jr (1972) Arterial pressure regulation. Overriding dominance of the kidneys in long-term regulation and in hypertension. Am J Med 52:584\u2013594","journal-title":"Am J Med"},{"key":"537_CR2","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1161\/01.HYP.15.6.547","volume":"15","author":"JE Hall","year":"1990","unstructured":"Hall JE, Mizelle L, Hildebrandt DA, Brands MW (1990) Abnormal pressure natriuresis. A cause or a consequence of hypertension? Hypertension 15:547\u2013559","journal-title":"Hypertension"},{"key":"537_CR3","doi-asserted-by":"crossref","first-page":"14552","DOI":"10.1073\/pnas.95.24.14552","volume":"95","author":"GH Kim","year":"1998","unstructured":"Kim GH, Masilamani S, Turner R, Mitchell C, Wade JB, Knepper MA (1998) The thiazide-sensitive Na-Cl cotransporter is an aldosterone-induced protein. Proc Natl Acad Sci USA 95:14552\u201314557","journal-title":"Proc Natl Acad Sci USA"},{"key":"537_CR4","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1073\/pnas.242735399","volume":"100","author":"FH Wilson","year":"2003","unstructured":"Wilson FH, Kahle KT, Sabath E, Lalioti MD, Rapson AK, Hoover RS, Hebert SC, Gamba G, Lifton RP (2003) Molecular pathogenesis of inherited hypertension with hyperkalemia: the Na-Cl cotransporter is inhibited by wild-type but no mutant WNK4. Proc Natl Acad Sci 100:680\u2013684","journal-title":"Proc Natl Acad Sci"},{"key":"537_CR5","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1172\/JCI17443","volume":"111","author":"CL Yang","year":"2003","unstructured":"Yang CL, Angell J, Mitchell R, Ellison DH (2003) WNK kinases regulate thiazide-sensitive Na-Cl cotransport. J Clin Invest 111:1039\u20131045","journal-title":"J Clin Invest"},{"key":"537_CR6","doi-asserted-by":"crossref","first-page":"10315","DOI":"10.1073\/pnas.0504422102","volume":"102","author":"BE Xu","year":"2005","unstructured":"Xu BE, Stippes S, Chu PY, Lazrak A, Li XJ, Lee BH, English JM, Ortega B, Huang CL, Cobb MH (2005) WNK1 activates SGK1 to regulate the epithelial sodium channel. Proc Natl Acad Sci USA 102:10315\u201310320","journal-title":"Proc Natl Acad Sci USA"},{"key":"537_CR7","doi-asserted-by":"crossref","first-page":"F245","DOI":"10.1152\/ajpcell.00411.2004","volume":"288","author":"G Gamba","year":"2005","unstructured":"Gamba G (2005) Role of WNK kinases in regulating tubular salt and potassium transport and in the development of hypertension. Am J Physiol 288:F245\u2013F252","journal-title":"Am J Physiol"},{"key":"537_CR8","doi-asserted-by":"crossref","first-page":"8558","DOI":"10.1073\/pnas.0603109103","volume":"103","author":"JB Wade","year":"2006","unstructured":"Wade JB, Fang L, Liu J, Li D, Yang C-L, Subramanya AR, Maouyo D, Mason A, Ellison DH, Welling PA (2006) WNK1 kinase isoform switch regulates renal potassium excretion. Proc Natl Acad Sci 103:8558\u20138563","journal-title":"Proc Natl Acad Sci"},{"key":"537_CR9","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/ng0995-76","volume":"11","author":"JH Hansson","year":"1995","unstructured":"Hansson JH, Nelson-Williams C, Suzuki H, Schild L, Shimkets R, Lu Y, Canessa C, Iwasaki T, Rossier B, Lifton RP (1995) Hypertension caused by truncated epithelial sodium channel gamma subunit: genetic heterogeneity of Liddle syndrome. Nat Genet 11:76\u201382","journal-title":"Nat Genet"},{"key":"537_CR10","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/0092-8674(94)90250-X","volume":"79","author":"RA Shimkets","year":"1994","unstructured":"Shimkets RA, Warnock DG, Bositis CM, Nelson-Williams C, Hansson JH, Schambelan M, Gill JR Jr, Ulick S, Milora RV, Findling JW, Canessa CM, Rossier BC, Lifton RP (1994) Liddle\u2019s syndrome: heritable human hypertension caused by mutations in the beta subunit of the epithelial sodium channel. Cell 79:407\u2013414","journal-title":"Cell"},{"key":"537_CR11","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1002\/j.1460-2075.1996.tb00593.x","volume":"15","author":"O Staub","year":"1996","unstructured":"Staub O, Dho S, Henry P, Correa J, Ishikawa T, McGlade J, Rotin D (1996) WW domains of Nedd4 bind to the proline-rich PY motifs in the epithelial Na+ channel deleted in Liddle\u2019s syndrome. EMBO J 15:2371\u20132389","journal-title":"EMBO J"},{"key":"537_CR12","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1073\/pnas.0511184103","volume":"103","author":"KK Knight","year":"2006","unstructured":"Knight KK, Olson DR, Zhou R, Snyder PM (2006) Liddle\u2019s syndrome mutations increasse Na+ transport through dual effects on epithelial Na+ surface expression and proteolytic cleavage. Proc Natl Acad Sci USA 103:2805\u20132808","journal-title":"Proc Natl Acad Sci USA"},{"key":"537_CR13","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1097\/00004872-200111000-00005","volume":"19","author":"S Disse-Nicodeme","year":"2001","unstructured":"Disse-Nicodeme S, Desitter I, Fiquet-Kempf B, Houot AM, Stern N, Delahousse M, Potier J, Ader JL, Jeunemaitre X (2001) Genetic heterogeneity of familial hyperkalemic hypertension. J Hypertens 19:1957\u20131964","journal-title":"J Hypertens"},{"key":"537_CR14","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/ng0697-202","volume":"16","author":"TA Mansfield","year":"1997","unstructured":"Mansfield TA, Simon DB, Farfel Z, Bia M, Tucci JR, Lebel M, Gutkin M, Vialettes B, Christofilis MA, Kauppinen-Makelin R, Mayan H, Risch N, Lifton RP (1997) Multilocus linkage of familial hyperkalaemia and hypertension, pseudohypoaldosteronism type II, to chromosomes 1q31-42 and 17p11-q21. Nat Genet 16:202\u2013205","journal-title":"Nat Genet"},{"key":"537_CR15","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1161\/01.HYP.8.2.93","volume":"8","author":"RD Gordon","year":"1986","unstructured":"Gordon RD (1986) Syndrome of hypertension and hyperkalemia with normal glomerular filtration rate. Hypertension 8:93\u2013102","journal-title":"Hypertension"},{"key":"537_CR16","doi-asserted-by":"crossref","first-page":"4025","DOI":"10.1210\/jc.2004-0037","volume":"89","author":"H Mayan","year":"2004","unstructured":"Mayan H, Munter G, Shaharabany M, Mouallem M, Pauzner R, Holtzman EJ, Farfel Z (2004) Hypercalciuria in familial hyperkalemia and hypertension accompanies hyperkalemia and precedes hypertension: description of a large family with the Q565E WNK4 mutation. J Clin Endocrin Metabol 89:4025\u20134030","journal-title":"J Clin Endocrin Metabol"},{"key":"537_CR17","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0272-6386(86)80011-7","volume":"7","author":"BL Margolis","year":"1986","unstructured":"Margolis BL, Lifschitz MD (1986) The Spitzer-Weinstein syndrome: one form of type IV renal tubular acidosis and its response to hydrochlorothiazide. Am J Kidney Dis 7:241\u2013244","journal-title":"Am J Kidney Dis"},{"key":"537_CR18","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/ki.1973.38","volume":"3","author":"A Spitzer","year":"1973","unstructured":"Spitzer A, Edelmann CM Jr, Goldberg LD, Henneman PH (1973) Short stature, hyperkalemia and acidosis: a defect in renal transport of potassium. Kidney Int 3:251\u2013257","journal-title":"Kidney Int"},{"key":"537_CR19","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0022-3476(74)80115-0","volume":"85","author":"SF Weinstein","year":"1974","unstructured":"Weinstein SF, Allan DM, Mendoza SA (1974) Hyperkalemia, acidosis, and short stature associated with a defect in renal potassium excretion. J Pediatr 85:355\u2013358","journal-title":"J Pediatr"},{"key":"537_CR20","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.1210\/jcem.87.7.8449","volume":"87","author":"H Mayan","year":"2002","unstructured":"Mayan H, Vered I, Mouallem M, Tzadok-Witkon M, Pauzner R, Farfel Z (2002) Pseudohypoaldosteronism type II: marked sensitivity to thiazides, hypercalciuria, normomagnesemia, and low bone mineral density. J Clin Endocrin Metab 87:3248\u20133254","journal-title":"J Clin Endocrin Metab"},{"key":"537_CR21","first-page":"2263","volume":"80","author":"RC Wilson","year":"1995","unstructured":"Wilson RC, Krozowski ZS, Li K, Obeyesekere VR, Razzaghy-Azar M, Harbison MD, Wei JQ, Shackleton CH, Funder JW, New MI (1995) A mutation in the HSD11B2 gene in a family with apparent mineralocorticoid excess. J Clin Endocrin Metab 80:2263\u20132266","journal-title":"J Clin Endocrin Metab"},{"key":"537_CR22","doi-asserted-by":"crossref","first-page":"3176","DOI":"10.1681\/ASN.2006060570","volume":"17","author":"G Morineau","year":"2006","unstructured":"Morineau G, Sulmont V, Salomon R, Fiquet-Kempf B, Jeunamaitre X, Nicod J, Ferrari P (2006) Apparent mineralocorticoid excess: report of six new cases and extensive personal experience. J Am Soc Nephrol 17:3176\u20133184","journal-title":"J Am Soc Nephrol"},{"key":"537_CR23","first-page":"2244","volume":"83","author":"S Dave-Sharma","year":"1998","unstructured":"Dave-Sharma S, Wilson RC, Harbison MD, Newfield R, Azar MR, Krozowski ZS, Funder JW, Shackleton CH, Bradlow HL, Wei JQ, Hertecant J, Moran A, Neiberger RE, Balfe JW, Fattah A, Daneman D, Akkurt HI, De Santis C, New MI (1998) Examination of genotype and phenotype relationships in 14 patients with apparent mineralocorticoid excess. J Clin Endocrin Metab 83:2244\u20132254","journal-title":"J Clin Endocrin Metab"},{"key":"537_CR24","doi-asserted-by":"crossref","first-page":"12790","DOI":"10.1073\/pnas.96.22.12790","volume":"96","author":"MI New","year":"1999","unstructured":"New MI, Wilson RC (1999) Steroid disorders in children: congenital adrenal hyperplasia and apparent mineralocorticoid excess. Proc Natl Acad Sci USA 96:12790\u201312797","journal-title":"Proc Natl Acad Sci USA"},{"key":"537_CR25","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1086\/301955","volume":"63","author":"A Li","year":"1998","unstructured":"Li A, Tedde R, Krozowski ZS, Pala A, Li KX, Shackleton CH, Mantero F, Palermo M, Stewart PM (1998) Molecular basis for hypertension in the \u201ctype II variant\u201d of apparent mineralocorticoid excess. Am J Hum Genet 63:370\u2013379","journal-title":"Am J Hum Genet"},{"key":"537_CR26","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1161\/01.HYP.34.4.638","volume":"34","author":"BS Nunez","year":"1999","unstructured":"Nunez BS, Rogerson FM, Mune T, Igarashi Y, Nakagawa Y, Phillipov G, Moudgil A, Travis LB, Palermo M, Shackleton C, White PC (1999) Mutants of 11beta-hydroxysteroid dehydrogenase (11-HSD2) with partial activity: improved correlations between genotype and biochemical phenotype in apparent mineralocorticoid excess. Hypertension 34:638\u2013642","journal-title":"Hypertension"},{"key":"537_CR27","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1126\/science.289.5476.119","volume":"289","author":"DS Geller","year":"2000","unstructured":"Geller DS, Farhi A, Pinkerton N, Fradley M, Moritz M, Spitzer A, Meinke G, Tsai FT, Sigler PB, Lifton RP (2000) Activating mineralocorticoid receptor mutation in hypertension exacerbated by pregnancy. Science 289:119\u2013123","journal-title":"Science"},{"key":"537_CR28","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/355262a0","volume":"355","author":"RP Lifton","year":"1992","unstructured":"Lifton RP, Dluhy RG, Powers M, Rich GM, Cook S, Ulick S, Lalouel JM (1992) A chimaeric 11-hydroxylase\/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension. Nature 355:262\u2013265","journal-title":"Nature"},{"key":"537_CR29","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/ng0992-66","volume":"2","author":"RP Lifton","year":"1992","unstructured":"Lifton RP, Dluhy RG, Powers M, Rich GM, Gutkin M, Fallo, F, Gill JR, Feld L, Ganguly A, Laidlaw JC, Murnaghan DJ, Kaufman C, Stockigt JR, Ulick S, Lalouel J-M (1992) Hereditary hypertension caused by chimaeric gene duplication and ectopic expression of aldosterone synthase. Nature Genet 2:66\u201374","journal-title":"Nature Genet"},{"key":"537_CR30","doi-asserted-by":"crossref","first-page":"8327","DOI":"10.1073\/pnas.89.17.8327","volume":"89","author":"L Pascoe","year":"1992","unstructured":"Pascoe L, Curnow KM, Slutsker L, Connell JM, Speiser PW, New MI, White PC (1992) Glucocorticoid-suppressible hyperaldosteronism results from hybrid genes created by unequal crossovers between CYP11B1 and CYP11B2. Proc Natl Acad Sci USA 89:8327\u20138331","journal-title":"Proc Natl Acad Sci USA"},{"key":"537_CR31","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/0039-128X(94)00010-A","volume":"60","author":"RG Dluhy","year":"1995","unstructured":"Dluhy RG, Lifton RP (1995) Glucocorticoid-remediable aldosteronism (GRA): Diagnosis, variability of phenotype and regulation of potassium homeostasis. Steroids 60:48\u201351","journal-title":"Steroids"},{"key":"537_CR32","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1067\/mpd.2001.112648","volume":"138","author":"RG Dluhy","year":"2001","unstructured":"Dluhy RG, Anderson B, Harlin B, Ingelfinger J, Lifton F (2001) Glucocorticoid-remediable aldosteronism is associated with severe hypertension in early childhood. J Pediatr 138:715\u2013720","journal-title":"J Pediatr"},{"key":"537_CR33","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1161\/01.HYP.31.1.445","volume":"31","author":"WR Litchfield","year":"1998","unstructured":"Litchfield WR, Anderson BF, Weiss RJ, Lifton RP, Dluhy RG (1998) Intracranial aneurysms and hemorrhagic stroke in glucocorticoid-remediable aldosteronism. Hypertension 31:445\u2013450","journal-title":"Hypertension"},{"key":"537_CR34","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.1210\/jcem.87.7.8647","volume":"87","author":"P Mulatero","year":"2002","unstructured":"Mulatero P, Morra di Cella S, Williams TA, Milan A, Mengozzi G, Chiandussi L, Gomez-Sanchez CE, Veglio F (2002) Glucocorticoid-remediable aldosteronism: low morbidity and mortality in a four-generation Italian pedigree. J Clin Endocrin Metab 87:3187\u20133191","journal-title":"J Clin Endocrin Metab"},{"key":"537_CR35","doi-asserted-by":"crossref","first-page":"3313","DOI":"10.1210\/jcem.85.9.6834","volume":"85","author":"M Stowasser","year":"2000","unstructured":"Stowasser M, Bachmann AW, Huggard PR, Rossetti TR, Gordon RD (2000) Treatment of familial hyperaldosteronism type I: only partial suppression of adrenocorticotropin required to correct hypertension. J Clin Endocrinol Metab 85:3313\u20133318","journal-title":"J Clin Endocrinol Metab"},{"key":"537_CR36","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/sj.jhh.1001152","volume":"15","author":"LJ Gates","year":"2001","unstructured":"Gates LJ, Benjamin N, Haites NE, MacConnachie AA, McLay JS (2001) Is random screening of value in detecting glucocorticoid-remediable aldosteronism within a hypertensive population? J Hum Hypertens 15:173\u2013176","journal-title":"J Hum Hypertens"},{"key":"537_CR37","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1136\/jmg.37.11.831","volume":"37","author":"AR Lafferty","year":"2000","unstructured":"Lafferty AR, Torpy DJ, Stowasser M, Taymana SE, Lin JP, Huggart P, Gordon RD, Stratakis CA (2000) A novel genetic locus for low renin hypertension: familial hyperaldosteronism type II maps to chromosome 7 (7p22). J Med Genet 37:831\u2013835","journal-title":"J Med Genet"},{"key":"537_CR38","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.mce.2003.10.006","volume":"217","author":"M Stowasser","year":"2004","unstructured":"Stowasser M, Gordon RD (2004) Primary aldosteronism - careful investigation is essential and rewarding. Mol Cell Endocrinol 217:33\u201339","journal-title":"Mol Cell Endocrinol"},{"key":"537_CR39","first-page":"3214","volume":"83","author":"DJ Torpy","year":"1998","unstructured":"Torpy DJ, Gordon RD, Lin JP, Huggard PR, Taymans SE, Stowasser M, Chrousos GP, Stratakis CA (1998) Familial hyperaldosteronism type II: description of a large kindred and exclusion of the aldosterone synthase (CYP11B2) gene. J Clin Endocrinol Metab 83:3214\u20133218","journal-title":"J Clin Endocrinol Metab"},{"key":"537_CR40","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1172\/JCI115046","volume":"87","author":"DM Hurley","year":"1991","unstructured":"Hurley DM, Accili D, Stratakis CA, Karl M, Vamvakopoulos N, Rorer E, Constantine K, Taylor SI, Chrousos GP (1991) Point mutation causing a single amino acid substitution in the hormone binding domain of the glucocorticoid receptor in familial glucocorticoid resistance. J Clin Invest 87:680\u2013686","journal-title":"J Clin Invest"},{"key":"537_CR41","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1210\/jc.2003-030450","volume":"89","author":"E Charmandari","year":"2004","unstructured":"Charmandari E, Kino T, Souvatzoglou E, Vottero A, Bhattacharyya N, Chrousos GP (2004) Natural glucocorticoid receptor mutants causing generalized glucocorticoid resistance: molecular genotype, genetic transmission, and clinical phenotype. J Clin Endocrinol Metab 89:1939\u20131949","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-007-0537-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00467-007-0537-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-007-0537-8.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-007-0537-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,10]],"date-time":"2019-12-10T09:46:06Z","timestamp":1575971166000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00467-007-0537-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10]]},"references-count":41,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["537"],"URL":"https:\/\/doi.org\/10.1007\/s00467-007-0537-8","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,10]]}}}